Abstract
We show that activation of postsynaptic inositol 1,4,5-tris-phosphate receptors (IP(3)Rs) with the IP(3)R agonist adenophostin A (AdA) produces large increases in AMPA receptor (AMPAR) excitatory postsynaptic current (EPSC) amplitudes at hippocampal CA1 synapses. Co-perfusion of the Ca(2+) chelator bis-(o-aminophenoxy)-N,N,N',N'-tetraacetic acid strongly inhibited AdA-enhanced increases in EPSC amplitudes. We examined the role of AMPAR insertion/anchoring in basal synaptic transmission. Perfusion of an inhibitor of synaptotagmin-soluble n-ethylmaleimide-sensitive factor attachment protein (SNAP) receptor SNARE-mediated exocytosis depressed basal EPSC amplitudes, whereas a peptide that inhibits GluR2/3 interactions with postsynaptic density-95 (PDZ) domain proteins glutamate receptor interacting protein (GRIP)/protein interacting with C-kinase-1 (PICK1) enhanced basal synaptic transmission. These results suggest that constitutive trafficking and anchoring of AMPARs help maintain basal synaptic transmission. The regulation of postsynaptic AMPAR trafficking involves synaptotagmin-SNARE-mediated vesicle exocytosis and interactions between AMPARs and the PDZ domains in GRIP/PICK1. We show that inhibitors of synaptotagmin-SNARE-mediated exocytosis, or interactions between AMPARs and GRIP/PICK1, attenuated AdA-enhanced increases in EPSC amplitudes. These results suggest that IP(3)R-mediated Ca(2+) release can enhance AMPAR EPSC amplitudes through mechanisms that involve AMPAR-PDZ interactions and/or synaptotagmin-SNARE-mediated receptor trafficking.
Publication types
-
Comparative Study
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adenosine / analogs & derivatives*
-
Adenosine / pharmacology
-
Animals
-
Animals, Newborn
-
Calcium / metabolism*
-
Calcium Channel Agonists / pharmacology
-
Calcium-Binding Proteins / chemistry
-
Calcium-Binding Proteins / pharmacology
-
Carrier Proteins / pharmacology
-
Chelating Agents / pharmacology
-
Complement C2 / pharmacology
-
Complement C2a
-
Drug Interactions
-
Egtazic Acid / analogs & derivatives*
-
Egtazic Acid / pharmacology
-
Electric Stimulation
-
Hippocampus / cytology*
-
Hippocampus / physiology
-
In Vitro Techniques
-
Membrane Glycoproteins / chemistry
-
Membrane Glycoproteins / pharmacology
-
Nerve Tissue Proteins / chemistry
-
Nerve Tissue Proteins / drug effects
-
Nerve Tissue Proteins / pharmacology
-
Nerve Tissue Proteins / physiology
-
Neurons / drug effects
-
Neurons / metabolism*
-
Neurons / physiology
-
Patch-Clamp Techniques / methods
-
Rats
-
Rats, Sprague-Dawley
-
Receptors, AMPA / chemistry
-
Receptors, AMPA / metabolism
-
Receptors, Glutamate / metabolism*
-
SNARE Proteins
-
Synapses / drug effects
-
Synapses / metabolism*
-
Synaptic Transmission / drug effects
-
Synaptic Transmission / physiology
-
Synaptotagmins
-
Vesicular Transport Proteins / chemistry
-
Vesicular Transport Proteins / pharmacology
Substances
-
Calcium Channel Agonists
-
Calcium-Binding Proteins
-
Carrier Proteins
-
Chelating Agents
-
Complement C2
-
Membrane Glycoproteins
-
Nerve Tissue Proteins
-
Receptors, AMPA
-
Receptors, Glutamate
-
SNARE Proteins
-
Vesicular Transport Proteins
-
postsynaptic density proteins
-
Synaptotagmins
-
adenophostin A
-
Egtazic Acid
-
Complement C2a
-
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
-
Adenosine
-
Calcium